Bristol-Myers Squibb Pharma Company Seeks Approval for License Amendment of Materials License No. 07-00455-40

Summary

The company has submitted a proposal to the relevant authorities for an amendment to its materials license, which will allow it to proceed with a license amendment process, following a finding that the proposed action is unlikely to have a significant impact on the environment.